Thomas Senderovitz

751 total citations
22 papers, 520 citations indexed

About

Thomas Senderovitz is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Thomas Senderovitz has authored 22 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Neurology. Recurrent topics in Thomas Senderovitz's work include Advancements in Transdermal Drug Delivery (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Thomas Senderovitz is often cited by papers focused on Advancements in Transdermal Drug Delivery (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Thomas Senderovitz collaborates with scholars based in Denmark, Switzerland and Sweden. Thomas Senderovitz's co-authors include Ulla I. Ivens, Jørgen Serup, Henrik Agersø, K Viskum, Mats O. Karlsson, Åsa Rembratt, A. Riis, Karl Broich, Marco Möller and Guido Rasi and has published in prestigious journals such as Nature Reviews Drug Discovery, The Lancet Oncology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Thomas Senderovitz

22 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Senderovitz Denmark 12 112 75 71 68 67 22 520
SeungJin Bae South Korea 17 49 0.4× 76 1.0× 63 0.9× 26 0.4× 114 1.7× 71 869
M. A. Mangues Spain 20 86 0.8× 226 3.0× 26 0.4× 9 0.1× 102 1.5× 49 1.0k
Zaher Khazaei Iran 14 71 0.6× 98 1.3× 25 0.4× 10 0.1× 61 0.9× 66 638
Anna Justyna Milewska Poland 15 35 0.3× 150 2.0× 50 0.7× 12 0.2× 30 0.4× 74 653
Helen S. Pentikis United States 14 72 0.6× 87 1.2× 11 0.2× 15 0.2× 32 0.5× 37 557
J. Cordero Spain 9 22 0.2× 57 0.8× 80 1.1× 149 2.2× 33 0.5× 17 532
Diane S. Aschenbrenner United States 9 35 0.3× 75 1.0× 12 0.2× 14 0.2× 51 0.8× 214 450
Xinhui Wang China 14 122 1.1× 258 3.4× 20 0.3× 37 0.5× 68 1.0× 46 1.1k
David J Margolis United States 5 24 0.2× 106 1.4× 394 5.5× 19 0.3× 41 0.6× 7 830

Countries citing papers authored by Thomas Senderovitz

Since Specialization
Citations

This map shows the geographic impact of Thomas Senderovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Senderovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Senderovitz more than expected).

Fields of papers citing papers by Thomas Senderovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Senderovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Senderovitz. The network helps show where Thomas Senderovitz may publish in the future.

Co-authorship network of co-authors of Thomas Senderovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Senderovitz. A scholar is included among the top collaborators of Thomas Senderovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Senderovitz. Thomas Senderovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sudhop, Thomas, Nikolai C. Brun, Claudia A. Riedel, et al.. (2019). Master protocols in clinical trials: a universal Swiss Army knife?. The Lancet Oncology. 20(6). e336–e342. 19 indexed citations
2.
Cave, Alison, et al.. (2019). Big Data – How to Realize the Promise. Clinical Pharmacology & Therapeutics. 107(4). 753–761. 14 indexed citations
3.
Eichler, Hans‐Georg, Brigitte Bloechl‐Daum, Karl Broich, et al.. (2018). Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?. Clinical Pharmacology & Therapeutics. 105(4). 912–922. 55 indexed citations
4.
Brøsen, Kim, Stig Ejdrup Andersen, Jeanett Borregaard, et al.. (2016). Clinical Pharmacology in Denmark in 2016 – 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality. Basic & Clinical Pharmacology & Toxicology. 119(6). 523–532. 10 indexed citations
5.
Senderovitz, Thomas. (2009). How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities. Expert Review of Clinical Pharmacology. 2(6). 585–587. 2 indexed citations
6.
Senderovitz, Thomas, et al.. (2005). Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers. BJOG An International Journal of Obstetrics & Gynaecology. 112(11). 1492–1499. 10 indexed citations
7.
Agersø, Henrik, et al.. (2004). Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. British Journal of Clinical Pharmacology. 58(4). 352–358. 58 indexed citations
8.
Rembratt, Åsa, et al.. (2004). Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55?70�years. European Journal of Clinical Pharmacology. 60(6). 397–402. 54 indexed citations
9.
Svensson, U, Thomas Senderovitz, & Mats O. Karlsson. (2003). Population PK/PD Modeling of Testosterone (T), LH and Dihydrotestosterone (DHT) Response to Single SC Degarelix in Male Volunteers. Clinical Pharmacology & Therapeutics. 73(2). 3 indexed citations
10.
11.
Rømsing, Janne, et al.. (2001). Pharmacokinetics of oral diclofenac and acetaminophen in children after surgery. Pediatric Anesthesia. 11(2). 205–213. 31 indexed citations
12.
13.
Ivens, Ulla I., et al.. (2001). Females have lower skin surface pH than men. Skin Research and Technology. 7(2). 90–94. 82 indexed citations
14.
Senderovitz, Thomas, Jørgen Vestbo, Jacob Frandsen, et al.. (1999). Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. Respiratory Medicine. 93(10). 715–718. 39 indexed citations
15.
Østergaard, Doris, et al.. (1999). BAYESIAN APPROACH FOR ESTIMATING LITHIUM STEADY STATE TROUGH CONCENTRATION. Therapeutic Drug Monitoring. 21(4). 460–460. 1 indexed citations
16.
Østergaard, Doris, et al.. (1999). BAYSIAN APPROCH FOR ESTIMATING ZUCLOPENTHIXOL STEADY STATE TROUGH CONCENTRATION. Therapeutic Drug Monitoring. 21(4). 460–460. 1 indexed citations
17.
Senderovitz, Thomas, et al.. (1998). [Discrepancies between medical records and dispensing records in two large hospital departments in Copenhagen].. PubMed. 160(27). 4055–8. 4 indexed citations
18.
Senderovitz, Thomas, Birgit Guldhammer Skov, & Fred R. Hirsch. (1994). Neuroendocrine characteristics in malignant lung tumors: Implications for diagnosis, treatment, and prognosis. Cancer treatment and research. 72. 143–154. 4 indexed citations
19.
Senderovitz, Thomas & K Viskum. (1994). Corticosteroids and tuberculosis. Respiratory Medicine. 88(8). 561–565. 36 indexed citations
20.
Senderovitz, Thomas & K Viskum. (1994). [Corticosteroids as adjuvants in the treatment of tuberculosis].. PubMed. 156(37). 5268–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by SeungJin Bae Breakdown of academic impact, for papers by M. A. Mangues Breakdown of academic impact, for papers by Zaher Khazaei Breakdown of academic impact, for papers by Anna Justyna Milewska Breakdown of academic impact, for papers by Helen S. Pentikis Breakdown of academic impact, for papers by J. Cordero Breakdown of academic impact, for papers by Diane S. Aschenbrenner Breakdown of academic impact, for papers by Xinhui Wang Breakdown of academic impact, for papers by David J Margolis
Rankless by CCL
2026